News for Sonnet BioTherapeutics Holdings, Inc. (SONN)

PRINCETON, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the ”œCompany” or ”œSonnet”) ( SONN), a clinical-stage company

Completion of SON-1010 (IL12-FHAB) monotherapy dose escalation in Phase 1 SB101 trial; Stable disease (SD) at four months post-initiation of dosing was seen in

**media[520657]**

PRINCETON, NJ, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the ”œCompany” or ”œSonnet”) ( SONN), a clinical-stage company d

**media[499686]**

**media[494623]**

PRINCETON, NJ, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company" or "Sonnet") (SONN), a clinical-stage company developing

**media[487604]**

**media[487308]**

The maximum tolerated dose (MTD) of SON-1010 was set at 1200 ng/kg, without dose-limiting toxicity or evidence of cytokine release syndrome at any dose level S

Sonnet BioTherapeutics reports progress in cancer trial

Pankaj Mohan, CEO of Sonnet discusses what this publication means in a Virtual Investor ”œWhat This Means” segment; access here PRINCETON, NJ, Dec. 04, 202

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 1,200 points on Wednesday. The Dow traded up 2.90% to 43,445.79 while the NA...

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.04%

Shares of Telesis Bio, Inc. TBIO rose sharply in today's pre-market trading session after the company announced a partnership with Beckman Coulter Life Sciences...

Shares of Greenland Technologies Holding Corporation GTEC rose sharply in today's pre-market trading after the company reported better-than-expected second-quar...

Loading... Loading... Shares of Jabil Inc. JBL fell sharply during Thursday's session following third-quarter results. Jabil reported third-quarter fiscal 202...

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 100 points on Wednesday. The Dow traded down 0.35% to 33,025.71 while the NASDAQ fell 2.45% to 12,817.76. The S&P 500 also fell, dropping, 1.48% to 4,184.98.

On Wednesday, 311 stocks hit new 52-week lows.